Inspire Medical Systems (NYSE:INSP) Posts Earnings Results, Beats Estimates By $0.23 EPS

Key Points

• Inspire Medical Systems reported a quarterly EPS of $0.45, exceeding analysts' estimates by $0.23, and saw a year-over-year revenue increase of 10.8%.
• Inspire Medical updated its FY 2025 EPS guidance to a range of $0.400-$0.500.
• The company's stock performed well, trading at $130.79 after an increase of $4.69 during midday trading on Monday.

Inspire Medical Systems (NYSE:INSP - Get Free Report) released its quarterly earnings results on Monday. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.23, Zacks reports. Inspire Medical Systems had a return on equity of 10.00% and a net margin of 7.92%. During the same quarter last year, the company earned $0.32 EPS. The business's quarterly revenue was up 10.8% on a year-over-year basis. Inspire Medical Systems updated its FY 2025 guidance to 0.400-0.500 EPS.

Inspire Medical Systems Price Performance

Shares of INSP stock traded up $4.69 during midday trading on Monday, reaching $130.79. 1,376,548 shares of the company traded hands, compared to its average volume of 603,921. The firm's 50 day simple moving average is $131.78 and its two-hundred day simple moving average is $154.63. Inspire Medical Systems has a 1-year low of $123.25 and a 1-year high of $225.00. The firm has a market cap of $3.86 billion, a PE ratio of 58.11, a price-to-earnings-growth ratio of 1.93 and a beta of 1.22.

Analyst Ratings Changes

INSP has been the topic of a number of research reports. Stifel Nicolaus lowered their price target on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Morgan Stanley reduced their price objective on shares of Inspire Medical Systems from $200.00 to $182.00 and set an "overweight" rating for the company in a research report on Tuesday, July 15th. Wall Street Zen downgraded shares of Inspire Medical Systems from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Robert W. Baird raised their price objective on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a research report on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price objective on shares of Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $208.55.

Institutional Investors Weigh In On Inspire Medical Systems

Hedge funds and other institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its position in shares of Inspire Medical Systems by 57.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 51,422 shares of the company's stock valued at $8,190,000 after acquiring an additional 18,857 shares during the period. Royal Bank of Canada lifted its position in shares of Inspire Medical Systems by 16.0% during the 1st quarter. Royal Bank of Canada now owns 32,769 shares of the company's stock valued at $5,220,000 after acquiring an additional 4,528 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Inspire Medical Systems during the 1st quarter valued at approximately $524,000. 94.91% of the stock is currently owned by institutional investors and hedge funds.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.